microRNAs associated with bromocriptine-treated prolactinomas
收藏官方服务：
资源简介：
microRNAs associated with bromocriptine-treated prolactinomas
应用场景：
创建时间：
2010-09-01
相关数据集
Exploratory Study Of The ERCC-1 Gene
This study is for patients with advanced or stage II and III colon or rectal cancer. The primary purpose of this research study is to determine if a particular protein in the patient’s blood will chan
NIAID Data Ecosystem80
Additional file 1 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1
Additional file 1: Table S1. Primers used for qRT-PCR in this study. Table S2. The clinical data of 15 prolactinoma patients. Table S3. siRNA used in this study. Table S4. Antibodies used in this stud
Figshare2024-02-14 更新40
Identification of Genes Regulated by Peptidylarginine Deiminase (PAD) Catalyzed Histone Citrullination in Prolactinomas
Identification of Genes Regulated by Peptidylarginine Deiminase (PAD) Catalyzed Histone Citrullination in Prolactinomas
NIAID Data Ecosystem30
A Subset of Genes Can Distinguish between Bortezomib Responsive Versus Bortezomib Resistant Myeloma
Gene expression profile (GEP) was analyzed from cultured bone marrow (BM) samples from patients with bortezomib responsive versus bortezomib resistant myeloma after 6-8 hours incubation in vitro with
NIAID Data Ecosystem50
A lncRNA HAR1B has a potential as a predictive marker for pazopanib therapy in patients with sarcoma. A lncRNA HAR1B has a potential as a predictive marker for pazopanib therapy in patients with sarcoma
Bone and soft tissue sarcomas are rare and highly heterogeneous mesenchymal malignancies. Their rarity makes it difficult to acquire clinical data of patients with specific histological subtypes of sa
NIAID Data Ecosystem40
